v3.26.3
Related parties (Details)
₩ in Thousands
Jun. 30, 2026
USD ($)
Jun. 30, 2026
KRW (₩)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
KRW (₩)
Dec. 31, 2024
USD ($)
Dec. 31, 2024
KRW (₩)
IfrsStatementLineItems [Line Items]            
Payables | $     $ 31,751   $ 30,371  
Receivables | $     52,918   50,618  
Payables | $ $ 7,725   7,725    
CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables   ₩ 4,269,591   ₩ 324,855   ₩ 39,769
Receivables   561,944   442,894   214,245
CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables | $ 31,751          
Receivables | $          
Total for all related parties [member] | Eun Jong Choi [Member]            
IfrsStatementLineItems [Line Items]            
Payables | $      
Receivables | $ 54,058   52,918   50,618  
Total for all related parties [member] | Eun Jong Choi [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables   5,235 [1]   24,855 [1]   [2]
Receivables   179,229 [1]   176,035 [1],[2]   169,595 [2]
Payables [2]       24,855    
Total for all related parties [member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables | $     32,435   31,751  
Receivables | $        
Total for all related parties [member] | CubeBio Holdings., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables | $ 32,435          
Receivables | $ $ 54,058          
Total for all related parties [member] | CubeBio Holdings., Ltd. [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables      
Receivables   55,859   45,564   44,650
Total for all related parties [member] | Dongsung D&C [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables   1,280,000    
Receivables   326,856   221,295  
Total for all related parties [member] | Noh Bin Park [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables         16,738
Receivables        
Total for all related parties [member] | Ho Sung Han [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables         12,553
Receivables        
Total for all related parties [member] | Jung Gon Kim [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables   1,900,000   300,000  
Receivables      
Total for all related parties [member] | Gyung Ha Yu [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables         10,478
Receivables        
Total for all related parties [member] | Well core [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables   1,011,973        
Receivables        
Total for all related parties [member] | Yun Woo Choo [Member] | CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables   72,383      
Receivables [1]        
CubeBio Co., Ltd. [Member]            
IfrsStatementLineItems [Line Items]            
Payables | $         $ 30,371  
[1] The Company provided a loan to Eun Jong Choi, a director of the Company, who resigned as CEO on January 30, 2026. As of June 30, 2026, compensation payable to the director was recorded as other payable and remained unpaid. Pursuant to a mutual agreement between the Company and the director, the unpaid compensation is expected to be applied against the outstanding loan receivable from the director. As the offsetting has not been executed as of June 30, 2026, the loan receivable and other payable are presented on a gross basis.
[2] The Company provided a loan to Eun Jong Choi, the CEO of the Company, who resigned as CEO on January 30, 2026. As of December 31, 2025, compensation payable to the CEO was recorded as other payable and remained unpaid. Pursuant to a mutual agreement between the Company and the CEO, the unpaid compensation is expected to be applied against the outstanding loan receivable from the CEO.